Geographic atrophy represents an advanced form of dry age-related macular degeneration that affects the retina, a part of the eye that sends information to the brain to enable sight. In this stage, the damage is so severe that it causes blind spots in the central vision of the patient. The common symptoms experienced by patients are central vision loss, difficulty in low-light conditions, and trouble seeing colors. An ophthalmologist can identify geographic atrophy using retinal imaging and a dilated examination.Ask an Analyst for Report Customization with TOC & List of figures: [FURL=https://bit.ly/3UJ3qID]https://bit.ly/3UJ3qID[/FURL]
The growing prevalence of retinal disorders and the expanding geriatric population are among the key factors stimulating the geographic atrophy market. Moreover, the increasing incidences of obesity and cardiovascular diseases (CVDs), on account of changing dietary patterns, sedentary lifestyles, and unhealthy habits, such as smoking, are acting as significant growth-inducing factors. Besides this, the rising usage of smartphones, laptops, televisions, etc., leading to prolonged and excessive screen time, is positively influencing the global market. Furthermore, the introduction of retinal gene therapies, which involve injecting adeno-associated virus (AAV) into the body to prevent the development of abnormal blood vessels, is also propelling the market growth.
Apart from this, the widespread adoption of autofluorescence imaging technology to visualize the retinal pigment epithelium (RPE) to assess the progression rate of the disease is further fueling the global market. Additionally, the inflating investments by various key players in developing imaging technologies, which will contribute to understanding the genesis and pathophysiological mechanisms of geographic atrophy, are also driving the market growth. In addition to this, the extensive R&D activities for launching innovative and effective drugs and the increasing expenditure on healthcare to facilitate access to affordable treatment options are anticipated to fuel the geographic atrophy market over the forecasted period.
Request a Free Sample Report: [URL=https://www.imarcgroup.com/geographic-atrophy-market/requestsample]https://www.imarcgroup.com/geographic-atrophy-market/requestsample[/URL]
Key Questions Answered in this Report:
How has the geographic atrophy market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the geographic atrophy market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the geographic atrophy market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [URL=Sales@imarcgroup.com]Sales@imarcgroup.com[/URL]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800